Athenion develops a  portfolio of exclusively licensed innovative drugs and medical technologies for future marketing and out-licensing.

We help scientists and companies to develop their inventions and products towards  marketability and regulatory approval in the world’s major health care markets.

To potential licensees from the pharmaceutical, medical technology and personal care industry, we offer a portfolio of late-stage technologies and drug compounds for in-licensing or marketing.